Home> Products> management plans

{ "products": [ { "_id": "66ed2340847254d7d1081d9a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Tablet IP 25 mg", "description": "ST GLIPTIN 25 is a pharmaceutical product containing Sitagliptin, an effective medication used to control blood sugar levels in individuals with Type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). This medication is often prescribed in combination with other antidiabetic drugs or diet and exercise plans to help manage blood sugar levels and reduce the risk of complications associated with diabetes, such as heart disease, nerve damage, and kidney problems.\n\n \nKey Ingredients:\n \n\nSitagliptin Tablet IP 25 mg: The active ingredient Sitagliptin works by increasing the levels of incretin hormones, which help regulate insulin production in response to meals. It also lowers the amount of glucose produced by the liver.\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: ST GLIPTIN 25 helps to manage blood sugar levels in adults with Type 2 diabetes, especially when used alongside proper diet and exercise.\nMinimal Risk of Hypoglycemia: Unlike some other diabetes medications, Sitagliptin generally does not cause hypoglycemia (low blood sugar) when used alone.\nPromotes Healthy Insulin Levels: Sitagliptin helps enhance the body’s natural release of insulin after meals, improving overall glucose management.\nSupports Heart Health: Maintaining stable blood sugar levels can reduce the risk of cardiovascular complications, making it an important part of a diabetes management plan.\n \nHow Does It Work?\n \n\nST GLIPTIN 25 (Sitagliptin) works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones play a key role in regulating blood glucose levels by stimulating insulin release and decreasing glucose production in the liver. By inhibiting DPP-4, Sitagliptin increases the levels of active incretin hormones, leading to better control over blood sugar levels, especially after meals.\n\n \nDirections for Use:\n \n\nDosage: The recommended dose is typically 25 mg taken once daily, as directed by your healthcare provider. This dosage may be adjusted based on the individual's health condition and response to treatment.\nMethod: ST GLIPTIN 25 can be taken with or without food. Swallow the tablet whole with a glass of water. To achieve the best results, it's important to take the medication at the same time each day.\nConsistency: It's essential to continue taking ST GLIPTIN 25 as prescribed, even if you feel well. Do not stop the medication without consulting your doctor.\n \nSide Effects:\n \n\nWhile ST GLIPTIN 25 is generally well-tolerated, some individuals may experience side effects such as:\n\nNausea or diarrhea\nHeadache\nUpper respiratory tract infections\nSore throat\nJoint pain", "price": 69.0, "discountamount": 20.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "same time", "Joint pain", "ST GLIPTIN", "proper diet", "Sore throat", "Minimal Risk", "DPP-4 enzyme", "Side Effects", "best results", "Heart Health", "Key Benefits", "nerve damage", "heart disease", "exercise plans", "insulin release", "natural release", "Key Ingredients", "kidney problems", "low blood sugar", "health condition", "DPP-4 inhibitors", "active ingredient", "insulin production", "glucose production", "healthcare provider", "effective medication", "blood glucose levels", "Sitagliptin Tablet IP", "pharmaceutical product", "Healthy Insulin Levels", "active incretin hormones", "Type 2 diabetes mellitus", "other antidiabetic drugs", "diabetes management plan", "stable blood sugar levels", "overall glucose management", "other diabetes medications", "cardiovascular complications", "Effective Blood Sugar Control", "dipeptidyl peptidase-4 inhibitors", "Upper respiratory tract infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1978, "imageuri": "https://productimages.withfloats.com/actual/66ed23433e1478b5013cfd1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/66ed23433e1478b5013cfd1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-20T07:24:48.197Z", "updatedon": "2024-09-20T07:28:37.557Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-tablet-ip-25-mg/1978", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 25 ", "category": "DIABETIC RANGE", "tags": [ "What is gliptin used for?", "", "What is the use of S gliptin tablet?" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e7ff07e47881008f6860e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIMETAZ CR 80 ", "description": "TRIMETAZ CR 80 \nTrimetazidine (80mg)\nIntroduction\nTRIMETAZ CR 80 is a medication containing Trimetazidine hydrochloride, formulated to treat angina pectoris and certain other cardiovascular conditions. It is known for its metabolic effects on the heart muscle, improving myocardial efficiency and reducing symptoms associated with ischemic heart disease.\n\nComposition\n\nTrimetazidine (80mg): The active ingredient, Trimetazidine, acts as a cellular metabolic agent that enhances myocardial glucose utilization and improves energy production in the heart muscle.\nMechanism of Action\nTrimetazidine exerts its therapeutic effects through several mechanisms:\n\nMetabolic Regulation: Shifts myocardial energy substrate utilization from fatty acids toward glucose oxidation, which is more efficient and requires less oxygen.\nAnti-ischemic Effect: Protects the heart against ischemic damage by preserving cellular energy metabolism and reducing oxidative stress.\nImprovement in Symptomatology: Reduces angina symptoms such as chest pain, shortness of breath, and exercise intolerance by enhancing myocardial function.\nIndications\nTRIMETAZ CR 80 is indicated for:\n\nChronic Stable Angina Pectoris: Used as adjunctive therapy in patients who are inadequately controlled with other anti-anginal medications.\nIschemic Heart Disease: Helps improve myocardial function and reduce symptoms associated with coronary artery disease.\nDosage and Administration\n\nThe usual dosage of TRIMETAZ CR 80 is one tablet (80mg) taken orally twice daily, preferably with meals.\nThe extended-release formulation ensures sustained therapeutic levels of Trimetazidine throughout the day.\nDosage adjustments may be necessary based on individual patient response and tolerance.\nSide Effects\nCommon side effects may include:\n\nHeadache\nDizziness\nNausea\nGastrointestinal disturbances (such as abdominal pain or diarrhea)\nSevere side effects are rare but may include:\n\nAllergic reactions (rash, itching, swelling)\nExtrapyramidal symptoms (involuntary movements)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with severe renal impairment or hepatic dysfunction, as Trimetazidine metabolism may be altered.\nMonitor patients for signs of extrapyramidal symptoms, especially in patients with Parkinson's disease or other movement disorders.\nAvoid abrupt discontinuation of Trimetazidine, as it may worsen angina symptoms.\nDrug Interactions\n\nTrimetazidine may interact with other medications that affect myocardial metabolism or cardiac function, including beta-blockers and calcium channel blockers. Close monitoring is recommended when used concomitantly.\nConclusion\nTRIMETAZ CR 80 is a valuable therapeutic option for managing chronic stable angina pectoris and ischemic heart disease by improving myocardial efficiency and reducing symptoms associated with cardiac ischemia. Its mechanism of action, focusing on metabolic modulation and anti-ischemic effects, makes it an effective adjunctive therapy in patients with inadequate symptom control on standard anti-anginal medications. Proper dosage, administration, and monitoring for side effects are essential to ensure safe and effective use of TRIMETAZ CR 80 in cardiovascular patients. Consultation with a healthcare provider is recommended for personalized treatment plans and management of cardiac conditions with TRIMETAZ CR 80.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 435.0, "discountamount": 130.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one tablet", "chest pain", "less oxygen", "fatty acids", "TRIMETAZ CR", "usual dosage", "heart muscle", "Proper dosage", "effective use", "abdominal pain", "angina symptoms", "ischemic damage", "Close monitoring", "cardiac ischemia", "oxidative stress", "cardiac function", "Drug Interactions", "active ingredient", "glucose oxidation", "metabolic effects", "energy production", "other medications", "Dosage adjustments", "Allergic reactions", "adjunctive therapy", "several mechanisms", "cardiac conditions", "healthcare provider", "Hepatic dysfunction", "myocardial function", "therapeutic effects", "Severe side effects", "Common side effects", "metabolic modulation", "Metabolic Regulation", "liver function tests", "involuntary movements", "anti-ischemic effects", "myocardial efficiency", "myocardial metabolism", "abrupt discontinuation", "ischemic heart disease", "Extrapyramidal symptoms", "cardiovascular patients", "coronary artery disease", "severe renal impairment", "Trimetazidine metabolism", "cellular metabolic agent", "other movement disorders", "calcium channel blockers", "cellular energy metabolism", "inadequate symptom control", "Trimetazidine hydrochloride", "valuable therapeutic option", "individual patient response", "extended-release formulation", "sustained therapeutic levels", "personalized treatment plans", "Gastrointestinal disturbances", "other anti-anginal medications", "myocardial glucose utilization", "Chronic Stable Angina Pectoris", "other cardiovascular conditions", "standard anti-anginal medications", "myocardial energy substrate utilization" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1938, "imageuri": "https://productimages.withfloats.com/actual/668e7ff3f07c99c3af8e8504.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7ff3f07c99c3af8e8504.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:34:56.538Z", "updatedon": "2024-07-10T12:34:56.538Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trimetaz-cr-80-/1938", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIMETAZ CR 80 ", "category": "CARDIOLOGYRANGE", "tags": [ "Trimetazidine 80mg price", "Trimetazidine 35 mg uses", "Trimetazidine 80 mg brand name", "When to stop taking trimetazidine", "Trimetazidine hydrochloride extended release CAPSU", "Trimetazidine mechanism of action", "Trimetazidine 35 mg brand name", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e79300ed04521b8687a0a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE OXY NASAL SPRAY ", "description": "Fluticatone XY\nFluticasone Furoate (0.028%w/w) Oxymetazoline Hydrochloride IP (0.050%w/w) & Benzalkonium Chloride Solution IP (0.030% w/w)\nIntroduction\nFluticatone XY is a nasal spray formulation combining Fluticasone Furoate, Oxymetazoline Hydrochloride, and Benzalkonium Chloride Solution. It is primarily used for the treatment of allergic rhinitis and nasal congestion, providing relief from symptoms such as nasal congestion, runny nose, and sneezing.\n\nComposition\n\nFluticasone Furoate (0.028% w/w): A synthetic glucocorticoid with potent anti-inflammatory properties, reducing inflammation in the nasal passages.\nOxymetazoline Hydrochloride IP (0.050% w/w): A nasal decongestant that constricts blood vessels in the nasal passages, reducing swelling and congestion.\nBenzalkonium Chloride Solution IP (0.030% w/w): A preservative and antimicrobial agent that helps maintain the sterility of the nasal spray solution.\nMechanism of Action\n\nFluticasone Furoate: Acts locally to reduce inflammation by inhibiting the production of inflammatory mediators such as cytokines, leukotrienes, and histamines.\nOxymetazoline Hydrochloride: Constricts the blood vessels in the nasal passages, thereby reducing nasal congestion and swelling.\nBenzalkonium Chloride: Ensures the sterility of the solution and prevents microbial contamination.\nIndications\nFluticatone XY is indicated for:\n\nAllergic Rhinitis: Provides relief from symptoms of seasonal or perennial allergic rhinitis, including nasal congestion, runny nose, sneezing, and itching.\nDosage and Administration\n\nShake the bottle gently before each use.\nFor adults and children over 12 years old, the usual dose is usually 1-2 sprays into each nostril once daily.\nDo not exceed the recommended dosage unless directed by a healthcare professional.\nIt may take several days of regular use to experience the full benefits of Fluticatone XY.\nSide Effects\nCommon side effects may include:\n\nNasal irritation or dryness\nSneezing\nHeadache\nThroat irritation\nNosebleeds (epistaxis)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nIncreased heart rate (especially with prolonged use of Oxymetazoline)\nPrecautions\n\nUse with caution in patients with hypertension, cardiovascular disease, or thyroid disorders due to the potential cardiovascular effects of Oxymetazoline.\nAvoid prolonged use of Oxymetazoline to prevent rebound congestion.\nDiscontinue use if allergic reactions occur and seek medical attention.\nDrug Interactions\n\nAvoid concurrent use with monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants, as they may potentiate the effects of Oxymetazoline.\nConclusion\nFluticatone XY offers effective relief from nasal congestion and symptoms of allergic rhinitis through its combination of Fluticasone Furoate, Oxymetazoline Hydrochloride, and Benzalkonium Chloride Solution. By targeting inflammation and congestion in the nasal passages, it helps improve breathing and alleviate discomfort associated with allergic reactions. Proper dosage and administration, along with adherence to precautions and monitoring for side effects, ensure safe and effective management of allergic rhinitis with Fluticatone XY. Consultation with a healthcare professional is recommended for personalized treatment and management plans.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "1-2 sprays", "usual dose", "runny nose", "regular use", "several days", "Proper dosage", "prolonged use", "full benefits", "blood vessels", "concurrent use", "nasal passages", "Fluticatone XY", "effective relief", "management plans", "nasal congestion", "Nasal irritation", "Drug Interactions", "medical attention", "thyroid disorders", "Throat irritation", "recommended dosage", "rebound congestion", "Allergic reactions", "nasal decongestant", "antimicrobial agent", "Fluticasone Furoate", "Common side effects", "effective management", "nasal spray solution", "Increased heart rate", "personalized treatment", "inflammatory mediators", "cardiovascular disease", "healthcare professional", "microbial contamination", "nasal spray formulation", "synthetic glucocorticoid", "More severe side effects", "tricyclic antidepressants", "perennial allergic rhinitis", "FLUTICATONE OXY NASAL SPRAY", "monoamine oxidase inhibitors", "Oxymetazoline Hydrochloride IP", "potential cardiovascular effects", "Benzalkonium Chloride Solution IP", "potent anti-inflammatory properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1936, "imageuri": "https://productimages.withfloats.com/actual/668e7933a466645e8fe5e227.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7933a466645e8fe5e227.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:06:08.926Z", "updatedon": "2024-07-10T12:06:08.926Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-oxy-nasal-spray-/1936", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Fluticatone XY", "category": "ASTHMARANGE", "tags": [ "Fluticone OX Nasal Spray Uses in Hindi", "Fluticone OX Nasal Spray is steroid or not", "Fluticasone Oxymetazoline Nasal Spray brands in In", "Fluticasone furoate and oxymetazoline hydrochlorid", "", "Fluticasone furoate and Oxymetazoline hydrochlorid", "Fluticone-OX Nasal Spray side effects", "Fluticasone Furoate and Oxymetazoline Hydrochlorid", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668d24ff75f1701d34699e32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 80 ", "description": "GLICLAGLAZE 80 \nGliclazide (80mg)\nOverview\nGLICLAGLAZE 80 is an oral medication containing Gliclazide at a dosage of 80 mg. Gliclazide belongs to the class of drugs known as sulfonylureas and is primarily used to manage type 2 diabetes mellitus. It helps control blood sugar levels by stimulating the release of insulin from the pancreatic beta cells. GLICLAGLAZE 80 is an effective treatment option for individuals who require oral hypoglycemic therapy to maintain optimal blood glucose levels.\n\nBenefits of Gliclazide\n\nBlood Sugar Control\n\nGliclazide effectively lowers blood glucose levels by increasing insulin secretion.\nHelps prevent complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy.\nReduced Risk of Hypoglycemia\n\nCompared to some other sulfonylureas, Gliclazide has a lower risk of causing hypoglycemia (low blood sugar levels).\nIt provides a balanced approach to managing blood sugar without causing excessive drops in glucose levels.\nCardiovascular Benefits\n\nStudies suggest that Gliclazide may have a protective effect on the cardiovascular system.\nIt may reduce the risk of cardiovascular events in diabetic patients, promoting overall heart health.\nImproved Glycemic Control\n\nHelps achieve and maintain target HbA1c levels, reflecting long-term glycemic control.\nCan be used in combination with other oral antidiabetic agents or insulin to enhance its effectiveness.\nUsage and Dosage\nGLICLAGLAZE 80 should be taken as prescribed by a healthcare professional. The typical starting dose is 40 to 80 mg daily, which can be adjusted based on the patient's blood glucose response. It is usually taken with meals to maximize its effectiveness and minimize gastrointestinal side effects. Consistent use and adherence to prescribed dosage are crucial for optimal results.\n\nIndications for Use\n\nType 2 Diabetes Mellitus: GLICLAGLAZE 80 is indicated for the management of type 2 diabetes in patients who cannot achieve adequate glycemic control through diet and exercise alone.\nCombination Therapy: It can be used in conjunction with other oral hypoglycemic agents or insulin to achieve better blood sugar control.\nSide Effects\nGLICLAGLAZE 80 is generally well-tolerated. However, some patients may experience side effects, including:\n\nHypoglycemia: Although less common, low blood sugar can occur, especially if meals are skipped or combined with excessive physical activity.\nGastrointestinal Issues: Nausea, abdominal pain, and diarrhea may occur but are usually mild and transient.\nAllergic Reactions: Rarely, allergic reactions such as skin rash, itching, or hives may occur.\nPrecautions and Contraindications\n\nLiver and Kidney Impairment: Patients with severe liver or kidney disease should use GLICLAGLAZE 80 with caution, as it may require dose adjustments.\nPregnancy and Lactation: Gliclazide is not recommended during pregnancy or breastfeeding. Alternative treatments should be considered.\nDrug Interactions: Inform your healthcare provider about all medications and supplements you are taking, as Gliclazide can interact with other drugs, potentially altering its effectiveness.\nConclusion\nGLICLAGLAZE 80 is a reliable and effective oral medication for managing type 2 diabetes mellitus. By stimulating insulin secretion, it helps control blood sugar levels, reducing the risk of diabetes-related complications. Its balanced approach to glycemic control, combined with potential cardiovascular benefits, makes GLICLAGLAZE 80 a valuable addition to diabetes management plans. Under the guidance of a healthcare professional, GLICLAGLAZE 80 can significantly improve the quality of life for individuals with type 2 diabetes, promoting better long-term health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 265.0, "discountamount": 79.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "skin rash", "lower risk", "40 to 80 mg", "other drugs", "severe liver", "Reduced Risk", "Consistent use", "kidney disease", "abdominal pain", "excessive drops", "optimal results", "dose adjustments", "diabetic patients", "insulin secretion", "valuable addition", "Drug Interactions", "Kidney Impairment", "protective effect", "balanced approach", "Allergic Reactions", "healthcare provider", "Combination Therapy", "other sulfonylureas", "Blood Sugar Control", "target HbA1c levels", "overall heart health", "cardiovascular events", "cardiovascular system", "typical starting dose", "pancreatic beta cells", "Alternative treatments", "blood glucose response", "low blood sugar levels", "healthcare professional", "Gastrointestinal Issues", "type 2 diabetes mellitus", "diabetes management plans", "adequate glycemic control", "effective oral medication", "long-term health outcomes", "oral hypoglycemic therapy", "long-term glycemic control", "effective treatment option", "excessive physical activity", "optimal blood glucose levels", "gastrointestinal side effects", "diabetes-related complications", "other oral hypoglycemic agents", "other oral antidiabetic agents", "potential cardiovascular benefits" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1922, "imageuri": "https://productimages.withfloats.com/actual/668d2505c34ba6457aa3fb4d.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668d2505c34ba6457aa3fb4d.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:54:39.186Z", "updatedon": "2024-07-09T11:54:39.186Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-80-/1922", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE 80 ", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 80mg side effects", "Gliclazide 80mg dosage", "Gliclazide 80mg Metformin 500mg", "Gliclazide 80mg price", "Gliclazide 80mg uses", "Gliclazide 80mg Uses in Hindi", "Gliclazide 80mg before or after meal" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f08f9d91d281c30c72c8a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN 5 ", "description": "GLIDAPAFLOZIN 5 \nDapagliflozin (5mg)\nIntroduction\nGLIDAPAFLOZIN 5 is a targeted medication designed to assist in the management of Type 2 diabetes. It contains 5 mg of Dapagliflozin, an SGLT2 inhibitor renowned for its efficacy in controlling blood glucose levels and supporting overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (5 mg): Dapagliflozin works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. By doing so, it reduces the reabsorption of glucose into the bloodstream, leading to increased glucose excretion through urine. This mechanism not only helps lower blood sugar levels but also contributes to weight management and may have cardiovascular benefits.\nBenefits\nGLIDAPAFLOZIN 5 offers several advantages for individuals with Type 2 diabetes. Its primary benefit lies in its ability to effectively lower blood glucose levels, which is crucial for diabetes management. Additionally, it may help in reducing body weight and blood pressure, making it a comprehensive treatment option.\n\nDosage and Administration\n\nDosage: The recommended dose is one 5 mg tablet per day. Dosage adjustments may be necessary based on individual response and tolerability, as advised by a healthcare professional.\nAdministration: GLIDAPAFLOZIN 5 should be taken in the morning, with or without food. It is important to maintain a consistent dosing schedule for optimal blood sugar control.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN 5 include urinary tract and genital infections due to increased glucose in the urine. Patients may also experience dehydration-related symptoms such as increased thirst and dry mouth. Monitoring for these side effects is important for overall health management.\n\nConclusion\nGLIDAPAFLOZIN 5 is an effective and targeted medication for individuals with Type 2 diabetes, providing a focused approach to blood sugar control. Its mechanism of action and potential benefits in weight and blood pressure management make it a valuable addition to diabetes treatment plans. Patients should work closely with their healthcare provider to determine the appropriate dosage and monitor for any potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-5-133428", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "food", "urine", "EMAIL", "Order", "Action", "thirst", "morning", "ability", "kidneys", "efficacy", "Patients", "Mechanism", "effective", "dry mouth", "Monitoring", "Conclusion", "body weight", "information", "individuals", "bloodstream", "reabsorption", "sterispharma", "Introduction", "sterisonline", "Dapagliflozin", "GLIDAPAFLOZIN", "CALL/WHATSAPP", "urinary tract", "primary benefit", "SGLT2 inhibitor", "Type 2 diabetes", "one 5 mg tablet", "focused approach", "valuable addition", "weight management", "glucose excretion", "Dosage adjustments", "appropriate dosage", "blood sugar levels", "genital infections", "several advantages", "potential benefits", "diabetes management", "healthcare provider", "individual response", "Common side effects", "targeted medication", "blood glucose levels", "Administration Dosage", "potential side effects", "cardiovascular benefits", "healthcare professional", "diabetes treatment plans", "overall metabolic health", "overall health management", "blood pressure management", "consistent dosing schedule", "optimal blood sugar control", "sodium-glucose cotransporter", "dehydration-related symptoms", "comprehensive treatment option" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1313, "imageuri": "https://productimages.withfloats.com/actual/665f08fac40ee9be01963b03.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f08fac40ee9be01963b03.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:30:49.993Z", "updatedon": "2024-06-04T12:30:49.993Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-5-/1313", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN 5 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6630a3904793c41fd8f760d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DANOZOLIS 100 ", "description": "DANOZOLIS 100 \nDanazol (100mg)\nDANOZOLIS 100 is a medication containing Danazol in a strength of 100mg per dosage unit. Danazol is a synthetic steroid derived from ethisterone, primarily used in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. It works by affecting certain hormones in the body to reduce symptoms associated with these conditions.\n\nKey Features of DANOZOLIS 100:\n\nUsage: Prescribed for the management of endometriosis, fibrocystic breast disease, and hereditary angioedema.\nMechanism of Action: Danazol suppresses the pituitary-ovarian axis, inhibiting the release of gonadotropins and thereby reducing estrogen levels.\nDosage: Typically taken orally in divided doses as directed by a healthcare professional.\nSide Effects: Common side effects may include weight gain, acne, oily skin, hot flashes, and changes in menstrual flow.\nPrecautions: It is important to follow dosage instructions carefully and inform your doctor of any existing medical conditions or medications being taken.\nStorage: Store at room temperature away from moisture and heat.\nDANOZOLIS 100, with its Danazol content, plays a crucial role in managing various hormone-related disorders under medical supervision. Always consult a healthcare provider for proper diagnosis and treatment plans tailored to individual needs.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 177.0, "discountamount": 53.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 866, "imageuri": "https://productimages.withfloats.com/actual/6630a3925c30785f2f7b6154.png", "tileimageuri": "https://productimages.withfloats.com/tile/6630a3925c30785f2f7b6154.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-30T07:53:52.304Z", "updatedon": "2024-06-12T12:36:15.594Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/danozolis-100-/866", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Danazol (100mg)", "category": "GYANECOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662f3f35e2fa911c8c2923c3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERITIME PLUS ", "description": "RISPERITIME PLUS \nRisperidone (2mg), Trihexyphenidyl (2mg)\nRisperitime Plus is a combination medication featuring Risperidone (2mg) and Trihexyphenidyl (2mg). It is primarily used to manage symptoms of psychiatric disorders such as schizophrenia and bipolar disorder. Risperidone helps in stabilizing mood and reducing hallucinations, while Trihexyphenidyl controls drug-induced movement disorders, ensuring comprehensive management of symptoms. This medication should be used under strict medical supervision due to potential side effects and interactions. Always consult your healthcare provider for personalized advice and treatment plans.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 65.0, "discountamount": 20.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mood", "symptoms", "Risperidone", "interactions", "schizophrenia", "hallucinations", "Trihexyphenidyl", "treatment plans", "RISPERITIME PLUS", "bipolar disorder", "personalized advice", "healthcare provider", "psychiatric disorders", "potential side effects", "combination medication", "comprehensive management", "strict medical supervision", "drug-induced movement disorders" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 777, "imageuri": "https://productimages.withfloats.com/actual/662f3f37e00b62b2b7823f17.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f3f37e00b62b2b7823f17.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T06:33:25.05Z", "updatedon": "2024-06-07T12:35:12.447Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//risperitime-plus-/777", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Risperidone (2mg), Trihexyphenidyl (2mg)", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d518ce6b4e65282a1dc798", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg", "description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)", "price": 238.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2181, "imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:26:22.554Z", "updatedon": "2025-09-25T10:26:22.554Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 400 CAP", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }